(CNBC) A novel Canadian treatment to halt the progression of multiple sclerosis (MS) is being hailed as revolutionary, after doctors and researchers used the new stem cell transplant method to treat the disease.
The results of the trial, published in The Lancet medical journal, showed long-term improvement of disease control in 23 out of 24 MS patients tested.
The treatment combined chemotherapy and a stem cell transplant. It halted relapses and the development of new brain lesions in 23 of 24 patients for a prolonged period, without the need for ongoing medication, reported online science news service Eureka News, citing The Lancet.
Advertisement - story continues below